AISAP, a leader in AI Point-of-Care Diagnostics, announced a landmark initiative in Ghana deploying its FDA-cleared AI cardiac diagnosis platform to support the country’s first nationwide training program for cardiac sonographers. In collaboration with the G-ACT Foundation, AISAP is creating a global model for bringing expert-level cardiac diagnostics to underserved communities.
Ghana faces a severe shortage of cardiologists, fewer than 30 serve its 35 million citizens. AISAP’s deployment demonstrates how its platform can bridge this gap, offering a scalable blueprint for the U.S., where nearly half of all counties lack a practicing cardiologist.
“AISAP brings world-class AI diagnostic capability that accelerates training, safeguards quality, and ensures every scan counts,” said Dr. Alexis K. Okoh, Executive Chairman of the G-ACT Foundation. “This partnership sets a new standard for accessible cardiovascular care across Ghana.”
“This project embodies our mission, access to advanced cardiac care should not depend on geography,” said Adiel Am-Shalom, CEO of AISAP. “We’re using the same FDA-cleared technology trusted by U.S. hospitals across Ghana’s frontlines. It’s proof that AISAP can help solve diagnostic shortages for rural U.S. hospitals.”
Developed with Sheba Medical Center, AISAP’s Point-of-Care Assisted Diagnosis (POCAD) platform uses deep learning trained on over 300,000 echocardiogram studies and 24 million video clips. It delivers real-time, expert-grade cardiac interpretation, including an Urgency Score for prioritizing cases and Quality Assurance guidance for non-specialists. The platform is already used by top U.S. institutions including Mayo Clinic, Stanford, and Mass General Brigham.